MNI: RIKSBANK LEAVES KEY RATE UNCHANGED AT 3.75%

MNI BRIEF: China To Hold Key Third Plenum On July 15-18

MNI Brief: China Third Plenum To Deepen Reforms

MNI: PBOC Net Injects CNY80 Bln Via OMO Thurs; Rates Unchanged

CHINA PBOC CONDUCTS CNY100 BILLION VIA 7-DAY REVERSE REPOS THURS

MNI: PBOC Sets Yuan Parity Higher At 7.1270 Thurs; -0.78% Y/Y

External Demand An Upside Risk to Riksbank Rate Path

BOE Financial Stability Report due at 10:30BST

Modest SEK Weakening Post Riksbank; High Chance Of August Cut

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

MNI BRIEF: Poilievre Calls QE 'Scam' And Would Limit BOC Remit

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

AZ/Oxford US trial data likely to see AZ file for emergency use approval (EUA)

US

Headlines suggest that the trial data for the AZ/Oxford vaccine in the US has seen 79% of Covid-19 cases prevented with no one who contracted Covid-19 who had taken the vaccine admitted to hospital.

  • Remember that AZ was awaiting a large enough "local" trial in the US in order to seek emergency use approval (EUA) of the vaccine in the US.
  • To receive EUA, AZ must now file a request with the FDA.
  • For the Pfizer/BioNTech vaccine, a request was filed on 20 November with EUA granted on December 11 (3 week later).
  • For the Moderna vaccine a request was filed on 30 November with EUA granted on 18 December (so one working day less than 3 weeks).
Political Risk BulletFixed Income BulletsBulletMarketsPolitical RiskForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.